Drugs - HealthQuill

At least 12 people have died, and 740 new patients were admitted to hospitals as dengue cases in the South Asian nation of Bangladesh registered the largest single-day rise last week.

Bangladesh reports highest single-day rise in dengue cases last week

At least 12 people have died, and 740 new patients were admitted to hospitals as dengue cases in the South Asian nation of.

by HealthQuill
September 22, 2025
0 Comments

The US drug regulator, the Food and Drug Administration, has approved Merck & Co.’s new formulation of its cancer drug Keytruda that can be administered under the skin for adults.

Drugs Health Pharma

US approves Merck’s skin injectable version of cancer drug Keytruda

The US drug regulator, the Food and Drug Administration, has approved Merck & Co.’s new formulation of its cancer drug Keytruda that can.

by HealthQuill
September 20, 2025
0 Comments

Swiss healthcare multinational F. Hoffmann-La Roche AG will acquire US-based 89bio Inc. for a deal worth up to $3.5 billion to expand its metabolic disease portfolio.

Drugs Health Pharma

Roche to buy 89bio Inc for $3.5 billion to expand metabolic disease portfolio

Swiss healthcare multinational F. Hoffmann-La Roche AG will acquire US-based 89bio Inc. for a deal worth up to $3.5 billion to expand its.

by HealthQuill
September 18, 2025
0 Comments

AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the disease, according to a company statement.

Drugs Health

AstraZeneca’s asthma drug fails end-stage trial in COPD

HQ Team September 17, 2025: AstraZeneca’s asthma drug Fasenra (benralizumab) has failed to meet its primary goal in a Phase III trial for.

by HealthQuill
September 17, 2025
0 Comments

https://www.novartis.com/research-and-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis

Drugs Health Pharma

Novartis signs $5.2 billion pact with China’s Argo Biopharmaceutical

HQ Team September 4, 2025: China’s Argo Biopharmaceutical Co., Ltd., and Switzerland’s Novartis AG have inked a $5.2 billion pact to develop new.

by HealthQuill
September 4, 2025
0 Comments

Swedish-British AstraZeneca Plc’s medicine baxdrostat lowered blood pressure in trial patients during an end-stage study, and the company plans to file for regulatory approvals by the end of the year.

Drugs Health Pharma

AstraZeneca’s medicine lowers BP, to file for early approvals

Swedish-British AstraZeneca Plc’s medicine baxdrostat lowered blood pressure in trial patients during an end-stage study, and the company plans to file for regulatory.

by HealthQuill
August 31, 2025
0 Comments

The USFDA has granted a standard approval for Eisai and Biogen's Alzheimer injection, Leqembi —the first treatment to secure the traditional approval, paving the way for wider insurance coverage of the drug.

Drugs

FDA warns Alzheimer patients on Leqembi to seek earlier scanning

HQ Team August 30, 2025: The U.S. Food and Drug Administration (FDA) is recommending an additional magnetic resonance imaging in Alzheimer’s disease patients.

by HealthQuill
August 30, 2025
0 Comments

Johnson & Johnson has stopped a mid-trial evaluation of a combination drug to treat people with a type of arthritis after the therapy failed to show “sufficient evidence” of benefit to the patients.

Drugs Health Pharma

J & J stops rheumatoid arthritis trial due to lack of ‘sufficient evidence’

Johnson & Johnson has stopped a mid-trial evaluation of a combination drug to treat people with a type of arthritis after the therapy.

by HealthQuill
August 29, 2025
0 Comments

Britain’s Medicines and Healthcare products Regulatory Agency has approved GSK Plc’s Blujepa, an oral antibiotic pill to treat uncomplicated urinary tract infections in females above 12 years and older, weighing at least 40 kilograms.

Drugs Health Pharma

GSK drug gets Britain’s nod to treat UTI patients 12 years and above

Britain’s Medicines and Healthcare products Regulatory Agency has approved GSK Plc’s Blujepa, an oral antibiotic pill to treat uncomplicated urinary tract infections in.